Literature DB >> 21061118

Low persistence of anticholinergic drug use in Sweden.

Love Linnér, Helena Schiöler, Eva Samuelsson, Ian Milsom, Fredrik Nilsson.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21061118     DOI： 10.1007/s00228-010-0917-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.

Authors:  Björn Wettermark; Niklas Hammar; Carl Michael Fored; C MichaelFored; Andrejs Leimanis; Petra Otterblad Olausson; Ulf Bergman; Ingemar Persson; Anders Sundström; Barbro Westerholm; Måns Rosén
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-07       Impact factor: 2.890

2.  A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag.

Authors:  Y S Hannestad; G Rortveit; H Sandvik; S Hunskaar
Journal:  J Clin Epidemiol       Date:  2000-11       Impact factor: 6.437

3.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

4.  The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW.

Authors:  Andreas M Pleil; Karen S Coyne; Pat Ray Reese; Zhanna Jumadilova; Eric S Rovner; Con J Kelleher
Journal:  Value Health       Date:  2005 Nov-Dec       Impact factor: 5.725

Review 5.  Which anticholinergic drug for overactive bladder symptoms in adults.

Authors:  J Hay-Smith; P Herbison; G Ellis; A Morris
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  How much is enough and who says so?

Authors:  Con J Kelleher; Andreas M Pleil; Pat Ray Reese; Somali Misra Burgess; Paul H Brodish
Journal:  BJOG       Date:  2004-06       Impact factor: 6.531

7.  Persistence of antimuscarinic drug use.

Authors:  Søren Brostrøm; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2008-12-24       Impact factor: 2.953

Review 8.  Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.

Authors:  G Nabi; J D Cody; G Ellis; P Herbison; J Hay-Smith
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
  8 in total
  6 in total

Review 1.  Urinary incontinence in women.

Authors:  Yoshitaka Aoki; Heidi W Brown; Linda Brubaker; Jean Nicolas Cornu; J Oliver Daly; Rufus Cartwright
Journal:  Nat Rev Dis Primers       Date:  2017-07-06       Impact factor: 52.329

Review 2.  The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials.

Authors:  Yuanshan Cui; Huantao Zong; Chenchen Yang; Huilei Yan; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2013-07-30       Impact factor: 2.370

3.  Tolerability and persistence in a large, prospective case series of women prescribed mirabegron.

Authors:  Jonathan Duckett; Aswini Balachandran
Journal:  Int Urogynecol J       Date:  2016-01-23       Impact factor: 2.894

4.  Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada.

Authors:  Adrian Wagg; Billy Franks; Barbara Ramos; Todd Berner
Journal:  Can Urol Assoc J       Date:  2015 Sep-Oct       Impact factor: 1.862

5.  Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.

Authors:  Andrea V Margulis; Marie Linder; Alejandro Arana; Anton Pottegård; Ina Anveden Berglind; Christine L Bui; Nina Sahlertz Kristiansen; Shahram Bahmanyar; Lisa J McQuay; Willem Jan Atsma; Kwame Appenteng; Milbhor D'Silva; Susana Perez-Gutthann; Jesper Hallas
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

6.  Overactive bladder in an integrated delivery system: a longitudinal cohort study.

Authors:  Jeffrey A Linder; Joel S Weissman; Harry Reyes Nieva; Stuart Lipsitz; R Sterling Haring; Julie DeAngelis; Rita M Kristy; Kevin R Loughlin
Journal:  BMC Health Serv Res       Date:  2020-05-20       Impact factor: 2.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.